Publisher' newest research report, the “Brain Disease Device and Software Industry Forecast” looks at past sales and reviews total world Brain Disease Device and Software sales in 2022, providing a comprehensive analysis by region and market sector of projected Brain Disease Device and Software sales for 2023 through 2029. With Brain Disease Device and Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Brain Disease Device and Software industry.
This Insight Report provides a comprehensive analysis of the global Brain Disease Device and Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Brain Disease Device and Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Brain Disease Device and Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Brain Disease Device and Software and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Brain Disease Device and Software.
The global Brain Disease Device and Software market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Brain Disease Device and Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Brain Disease Device and Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Brain Disease Device and Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Brain Disease Device and Software players cover United Imaging Healthcare Co., Ltd, Koninklijke Philips N.V., GE, Canon, Inc, Siemens Healthineers AG, Vuno Co., Ltd, Fujifilm Holdings Corporation, Aspect Imaging and IXICO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Brain Disease Device and Software market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Brain Disease Device
Brain Disease Software
Segmentation by application
Hospitals and Clinics
Diagnostic Imaging Centers
Ambulatory Surgical Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
United Imaging Healthcare Co., Ltd
Koninklijke Philips N.V.
GE
Canon, Inc
Siemens Healthineers AG
Vuno Co., Ltd
Fujifilm Holdings Corporation
Aspect Imaging
IXICO
QMENTA
Cortechs.ai
Quantib
Brainomix
Qure.AI
Imaging Biometrics, LLC
A.I. Analysis, Inc
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Brain Disease Device and Software Market Size 2018-2029
2.1.2 Brain Disease Device and Software Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Brain Disease Device and Software Segment by Type
2.2.1 Brain Disease Device
2.2.2 Brain Disease Software
2.3 Brain Disease Device and Software Market Size by Type
2.3.1 Brain Disease Device and Software Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Brain Disease Device and Software Market Size Market Share by Type (2018-2023)
2.4 Brain Disease Device and Software Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Diagnostic Imaging Centers
2.4.3 Ambulatory Surgical Centers
2.5 Brain Disease Device and Software Market Size by Application
2.5.1 Brain Disease Device and Software Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Brain Disease Device and Software Market Size Market Share by Application (2018-2023)
3 Brain Disease Device and Software Market Size by Player
3.1 Brain Disease Device and Software Market Size Market Share by Players
3.1.1 Global Brain Disease Device and Software Revenue by Players (2018-2023)
3.1.2 Global Brain Disease Device and Software Revenue Market Share by Players (2018-2023)
3.2 Global Brain Disease Device and Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Brain Disease Device and Software by Regions
4.1 Brain Disease Device and Software Market Size by Regions (2018-2023)
4.2 Americas Brain Disease Device and Software Market Size Growth (2018-2023)
4.3 APAC Brain Disease Device and Software Market Size Growth (2018-2023)
4.4 Europe Brain Disease Device and Software Market Size Growth (2018-2023)
4.5 Middle East & Africa Brain Disease Device and Software Market Size Growth (2018-2023)
5 Americas
5.1 Americas Brain Disease Device and Software Market Size by Country (2018-2023)
5.2 Americas Brain Disease Device and Software Market Size by Type (2018-2023)
5.3 Americas Brain Disease Device and Software Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Brain Disease Device and Software Market Size by Region (2018-2023)
6.2 APAC Brain Disease Device and Software Market Size by Type (2018-2023)
6.3 APAC Brain Disease Device and Software Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Brain Disease Device and Software by Country (2018-2023)
7.2 Europe Brain Disease Device and Software Market Size by Type (2018-2023)
7.3 Europe Brain Disease Device and Software Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Brain Disease Device and Software by Region (2018-2023)
8.2 Middle East & Africa Brain Disease Device and Software Market Size by Type (2018-2023)
8.3 Middle East & Africa Brain Disease Device and Software Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Brain Disease Device and Software Market Forecast
10.1 Global Brain Disease Device and Software Forecast by Regions (2024-2029)
10.1.1 Global Brain Disease Device and Software Forecast by Regions (2024-2029)
10.1.2 Americas Brain Disease Device and Software Forecast
10.1.3 APAC Brain Disease Device and Software Forecast
10.1.4 Europe Brain Disease Device and Software Forecast
10.1.5 Middle East & Africa Brain Disease Device and Software Forecast
10.2 Americas Brain Disease Device and Software Forecast by Country (2024-2029)
10.2.1 United States Brain Disease Device and Software Market Forecast
10.2.2 Canada Brain Disease Device and Software Market Forecast
10.2.3 Mexico Brain Disease Device and Software Market Forecast
10.2.4 Brazil Brain Disease Device and Software Market Forecast
10.3 APAC Brain Disease Device and Software Forecast by Region (2024-2029)
10.3.1 China Brain Disease Device and Software Market Forecast
10.3.2 Japan Brain Disease Device and Software Market Forecast
10.3.3 Korea Brain Disease Device and Software Market Forecast
10.3.4 Southeast Asia Brain Disease Device and Software Market Forecast
10.3.5 India Brain Disease Device and Software Market Forecast
10.3.6 Australia Brain Disease Device and Software Market Forecast
10.4 Europe Brain Disease Device and Software Forecast by Country (2024-2029)
10.4.1 Germany Brain Disease Device and Software Market Forecast
10.4.2 France Brain Disease Device and Software Market Forecast
10.4.3 UK Brain Disease Device and Software Market Forecast
10.4.4 Italy Brain Disease Device and Software Market Forecast
10.4.5 Russia Brain Disease Device and Software Market Forecast
10.5 Middle East & Africa Brain Disease Device and Software Forecast by Region (2024-2029)
10.5.1 Egypt Brain Disease Device and Software Market Forecast
10.5.2 South Africa Brain Disease Device and Software Market Forecast
10.5.3 Israel Brain Disease Device and Software Market Forecast
10.5.4 Turkey Brain Disease Device and Software Market Forecast
10.5.5 GCC Countries Brain Disease Device and Software Market Forecast
10.6 Global Brain Disease Device and Software Forecast by Type (2024-2029)
10.7 Global Brain Disease Device and Software Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 United Imaging Healthcare Co., Ltd
11.1.1 United Imaging Healthcare Co., Ltd Company Information
11.1.2 United Imaging Healthcare Co., Ltd Brain Disease Device and Software Product Offered
11.1.3 United Imaging Healthcare Co., Ltd Brain Disease Device and Software Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 United Imaging Healthcare Co., Ltd Main Business Overview
11.1.5 United Imaging Healthcare Co., Ltd Latest Developments
11.2 Koninklijke Philips N.V.
11.2.1 Koninklijke Philips N.V. Company Information
11.2.2 Koninklijke Philips N.V. Brain Disease Device and Software Product Offered
11.2.3 Koninklijke Philips N.V. Brain Disease Device and Software Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Koninklijke Philips N.V. Main Business Overview
11.2.5 Koninklijke Philips N.V. Latest Developments
11.3 GE
11.3.1 GE Company Information
11.3.2 GE Brain Disease Device and Software Product Offered
11.3.3 GE Brain Disease Device and Software Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 GE Main Business Overview
11.3.5 GE Latest Developments
11.4 Canon, Inc
11.4.1 Canon, Inc Company Information
11.4.2 Canon, Inc Brain Disease Device and Software Product Offered
11.4.3 Canon, Inc Brain Disease Device and Software Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Canon, Inc Main Business Overview
11.4.5 Canon, Inc Latest Developments
11.5 Siemens Healthineers AG
11.5.1 Siemens Healthineers AG Company Information
11.5.2 Siemens Healthineers AG Brain Disease Device and Software Product Offered
11.5.3 Siemens Healthineers AG Brain Disease Device and Software Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Siemens Healthineers AG Main Business Overview
11.5.5 Siemens Healthineers AG Latest Developments
11.6 Vuno Co., Ltd
11.6.1 Vuno Co., Ltd Company Information
11.6.2 Vuno Co., Ltd Brain Disease Device and Software Product Offered
11.6.3 Vuno Co., Ltd Brain Disease Device and Software Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Vuno Co., Ltd Main Business Overview
11.6.5 Vuno Co., Ltd Latest Developments
11.7 Fujifilm Holdings Corporation
11.7.1 Fujifilm Holdings Corporation Company Information
11.7.2 Fujifilm Holdings Corporation Brain Disease Device and Software Product Offered
11.7.3 Fujifilm Holdings Corporation Brain Disease Device and Software Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Fujifilm Holdings Corporation Main Business Overview
11.7.5 Fujifilm Holdings Corporation Latest Developments
11.8 Aspect Imaging
11.8.1 Aspect Imaging Company Information
11.8.2 Aspect Imaging Brain Disease Device and Software Product Offered
11.8.3 Aspect Imaging Brain Disease Device and Software Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Aspect Imaging Main Business Overview
11.8.5 Aspect Imaging Latest Developments
11.9 IXICO
11.9.1 IXICO Company Information
11.9.2 IXICO Brain Disease Device and Software Product Offered
11.9.3 IXICO Brain Disease Device and Software Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 IXICO Main Business Overview
11.9.5 IXICO Latest Developments
11.10 QMENTA
11.10.1 QMENTA Company Information
11.10.2 QMENTA Brain Disease Device and Software Product Offered
11.10.3 QMENTA Brain Disease Device and Software Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 QMENTA Main Business Overview
11.10.5 QMENTA Latest Developments
11.11 Cortechs.ai
11.11.1 Cortechs.ai Company Information
11.11.2 Cortechs.ai Brain Disease Device and Software Product Offered
11.11.3 Cortechs.ai Brain Disease Device and Software Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Cortechs.ai Main Business Overview
11.11.5 Cortechs.ai Latest Developments
11.12 Quantib
11.12.1 Quantib Company Information
11.12.2 Quantib Brain Disease Device and Software Product Offered
11.12.3 Quantib Brain Disease Device and Software Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Quantib Main Business Overview
11.12.5 Quantib Latest Developments
11.13 Brainomix
11.13.1 Brainomix Company Information
11.13.2 Brainomix Brain Disease Device and Software Product Offered
11.13.3 Brainomix Brain Disease Device and Software Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Brainomix Main Business Overview
11.13.5 Brainomix Latest Developments
11.14 Qure.AI
11.14.1 Qure.AI Company Information
11.14.2 Qure.AI Brain Disease Device and Software Product Offered
11.14.3 Qure.AI Brain Disease Device and Software Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Qure.AI Main Business Overview
11.14.5 Qure.AI Latest Developments
11.15 Imaging Biometrics, LLC
11.15.1 Imaging Biometrics, LLC Company Information
11.15.2 Imaging Biometrics, LLC Brain Disease Device and Software Product Offered
11.15.3 Imaging Biometrics, LLC Brain Disease Device and Software Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Imaging Biometrics, LLC Main Business Overview
11.15.5 Imaging Biometrics, LLC Latest Developments
11.16 A.I. Analysis, Inc
11.16.1 A.I. Analysis, Inc Company Information
11.16.2 A.I. Analysis, Inc Brain Disease Device and Software Product Offered
11.16.3 A.I. Analysis, Inc Brain Disease Device and Software Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 A.I. Analysis, Inc Main Business Overview
11.16.5 A.I. Analysis, Inc Latest Developments
12 Research Findings and Conclusion
*If Applicable.